Cidara Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Cidara Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CDTX

Cidara Therapeutics, Inc. engages in developing targeted immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases. Its platform, Cloudbreak, enables development of novel drug-Fc conjugates (DFCs) that inhibit specific disease targets while simultaneously engaging the immune system. 

CEO
Jeffrey L. Stein
CEOJeffrey L. Stein
Employees
38
Employees38
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2012
Founded2012
Employees
38
Employees38

CDTX Key Statistics

Market cap
2.43B
Market cap2.43B
Price-Earnings ratio
-8.13
Price-Earnings ratio-8.13
Dividend yield
Dividend yield
Average volume
1.36M
Average volume1.36M
High today
$96.98
High today$96.98
Low today
$89.46
Low today$89.46
Open price
$91.27
Open price$91.27
Volume
1.17M
Volume1.17M
52 Week high
$96.98
52 Week high$96.98
52 Week low
$10.14
52 Week low$10.14

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CDTX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.